116 related articles for article (PubMed ID: 3029003)
1. Cytogenetic effects of multiagent chemotherapy on the peripheral lymphocytes of patients with small cell lung cancer.
Tominaga K; Shinkai T; Saijo N; Eguchi K; Sasaki Y; Sakurai M; Suga J; Nakajima T; Ochi H; Suemasu K
Jpn J Cancer Res; 1986 Dec; 77(12):1241-8. PubMed ID: 3029003
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
4. Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases.
Koide N; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Miyabayashi H; Terai N; Amano J
Surg Today; 2003; 33(4):294-8. PubMed ID: 12707827
[TBL] [Abstract][Full Text] [Related]
5. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
8. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
Yanagawa H; Bando H; Takishita Y
Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
[TBL] [Abstract][Full Text] [Related]
9. Comparison of carboplatin/etoposide/vincristine with cisplatin/etoposide as combination chemotherapy for small cell lung cancer.
Kumagai M; Kutsuzawa T; Fuyuno G; Kondo T; Shioya S; Ohta Y
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):209-14. PubMed ID: 8956462
[TBL] [Abstract][Full Text] [Related]
10. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
Urban T; Chastang C; Lebas FX; Duhamel JP; Adam G; Darse J; Bréchot JM; Lebeau B
Cancer; 1999 Dec; 86(11):2238-45. PubMed ID: 10590363
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy for small cell lung cancer].
Fukuoka M; Takada M; Masuda N; Furuse K; Saijo N; Ikegami H; Nishiwaki Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():225-31. PubMed ID: 7516450
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic effects of etoposide (VP-16) on human lymphocytes; with special reference to the relation between sister chromatid exchange and chromatid breakage.
Tominaga K; Shinkai T; Saijo N; Nakajima T; Ochi H; Suemasu K
Jpn J Cancer Res; 1986 Apr; 77(4):385-91. PubMed ID: 3084428
[TBL] [Abstract][Full Text] [Related]
13. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
[No Abstract] [Full Text] [Related]
14. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
[TBL] [Abstract][Full Text] [Related]
15. [CAV-PVP chemotherapy and sequential thoracic irradiation (TI) for patients with limited (LD) small cell lung cancer (SCLC)].
Ueoka H; Ohnoshi T; Hiraki S; Kamei H; Tabata M; Shibayama T; Miyatake K; Gemba K; Hiyama J; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():218-24. PubMed ID: 8007469
[TBL] [Abstract][Full Text] [Related]
16. Sister chromatid exchanges induced in human lymphocytes by cis-diamminedichloroplatinum (II).
Tominaga K; Shinkai T; Saijo N; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Nakajima T
Jpn J Clin Oncol; 1984 Dec; 14(4):659-65. PubMed ID: 6542944
[TBL] [Abstract][Full Text] [Related]
17. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
